EKElizaveta O. Kotova

Elizaveta O. Kotova

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Elizaveta O. Kotova has a total of 103 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Arterial hypertension in glomerulonephritis: clinical features and phenotyping based on ambulatory blood pressure monitoring

    by B. I. Komilova, K. A. Demyanova, N. L. Kozlovskaya, E. O. Kotova, T. V. Zhdanova, Zh. D. Kobalava, Б. И. Комилова, К. А. Демьянова, Н. Л. Козловская, Е. О. Котова, et al.

    Arterial hypertension (AH) is closely associated with glomerular diseases (GD) and contributes substantially to the progression of chronic kidney disease (CKD), thereby affecting treatment outcomes and prognosis. The pathogenetic mechanisms underlying AH in patients with GD are highly heterogeneous, resulting in distinct blood pressure (BP) phenotypes that can be identified only by ambulatory blood pressure monitoring (ABPM). However, despite recommendations in clinical guidelines, ABPM is rarely used routinely in this patient population. Office blood pressure measurements do not accurately reflect the overall BP profile, while the limited number of comprehensive studies using ABPM has resulted in a lack of optimal clinical approaches. Aim of the study: To characterize AH phenotypes and ambulatory BP measurements in patients with GD, thereby facilitating a personalized approach, optimizing antihypertensive therapy, and improving long-term clinical outcomes. Materials and methods: A single center, observational cohort study included 77 patients with primary glomerulonephritis and kidney involvement secondary to systemic diseases. BP phenotypes using three office BP measurements and ABPM. Results: Office BP ≥140/90 mmHg was detected in 49.3% of patients. Based on ABPM, uncontrolled AH was determined in 42.8% of patients, masked AH in 11.7%, and isolated nocturnal AH (INAH) in 6.5%. True BP control was achieved in 39%. The predominant GD subtypes were IgA nephropathy (35.3%) and focal segmental glomerulosclerosis (FSGS, 29.4%). True BP control was achieved in half of the patients with IgA nephropathy. With advancing CKD, the proportion of patients with uncontrolled AH increased, reaching 66.7% at stage 3b. AH phenotypes differed significantly across all BP parameters (pConclusions : In nearly one-fifth of patients with GD, AH phenotypes detectable only by ABPM were identified: masked AH in 11.7% and isolated nocturnal AH in 6.5%. As glomerular filtration rate (GFR) declines, the distribution of AH phenotype changed, with sustained AH predominating from CKD stage 3b onwards. Office BP measurements are insufficient to assess the true BP profile. ABPM should be used more widely for the timely diagnosis of AH in early stages of CKD and to guide the selection of appropriate antihypertensive therapy.

  • Open Access

    Clinical and prognostic significance of domain approach in patients with chronic heart failure and senile asthenia

    by Zhanna D. Kobalava, Alexandra Y. Moiseeva, Abdullah Al-Autairi, Elizaveta O. Kotova

    Aim. To characterize the features of the course of decompensated heart failure in hospitalized elderly patients depending on the domains (clinical, psychocognitive, functional and social), as well as to study the effect of the number of domains on the prognosis. Materials and methods. A prospective study included 150 patients over 75 years old [median age (IQR) 83.0 [77.8–87.0] years, 38% (n = 57) were men] admitted to a multidisciplinary hospital for chronic heart failure (CHF) decompensation, who were assessed for the prevalence of HFA-ESC domains (2019) – clinical, psychocognitive, functional and social. All patients underwent traditional laboratory and instrumental examination, NT-proBNP testing, echocardiographic examination, as well as body composition was assessed using bioimpedance analysis on the 5th day of hospitalization. The combined endpoint was a combination of death from all causes and repeated hospitalizations for CHF within 180 days. Results. 96.7% (n = 145) of senile patients with CHF had at least one domain of senile asthenia, the presence of all four domains was observed in more than a third of patients. Disorders in the psychocognitive and social spheres were the most common – 88.7% (n = 133) and 74.0% (n = 111), respectively, and clinical and functional domains were less common in 64.0% (n = 96) and 56.7% (n = 85) of patients, respectively. Patients with a large number of domains were characterized by an older age, a greater degree of physical activity restriction and the severity of CHF symptoms, were more often unmarried (including widowers, single and divorced), and most patients lived in a nursing home. A greater number of domains of senile asthenia was associated with a higher incidence of events for the combined endpoint – all-cause death and/or repeated hospitalization for CHF (Log Rank 10.76; p 0.03). In a comprehensive analysis, the presence of all four domains of fragility syndrome increases the risk of combined events from the primary endpoint by 2.5 times (odds ratio 2.5; 95% confidence interval 1.1–5.7, p 0.05), hospital mortality by 14.7 times (odds ratio 14.7, 95% confidence interval 3.3–66.4; p 0.05). Conclusion. A domain-based approach to determining the severity and prognosis of CHF in "fragile" senile patients seems to be a necessary and convenient tool for identifying a special group of patients at high risk of unfortunate outcome that requires a multidisciplinary approach together with a geriatric team.

  • Open Access

    Course and prognosis of heart failure in patients with frailty syndrome

    by Zh. D. Kobalava, A. Yu. Moiseeva, A. Al Autairi, E. O. Kotova

    Aim. To study the prevalence of frailty syndrome and major geriatric syndromes in hospitalized patients with heart failure (HF), as well as the prognosis depending on frailty severity.Material and methods. We prospectively included 250 patients over 75 years old, hospitalized for decompensated HF (median age, 83,0 [77,0-86,0] years; men, 41,6% (n=104)). In addition to traditional paraclinical investigations, including N-terminal pro-brain natriuretic peptide and echocardiography, all patients were assessed for frailty using the "Age Is Not a Barrier" questionnaire on the 5th day of hospitalization. Score of 2 or less was recognized as absence of frailty, while score of 3-4 — as probable prefrailty, and score of 5-7 — probable frailty. Patients with intermediate score of 3-4 were given a brief physical functioning tests to clarify the frailty. To assess the prevalence of other geriatric syndromes, all patients underwent cognitive function assessment using the Montreal Cognitive Assessment and functional independence using the Barthel scale. The primary endpoint was all-cause inhospital mortality.Results. The prevalence of SSA was 64,0% (n=160) in hospitalized patients with HF. The frequency of preserved left ventricular ejection fraction in patients with HF and frailty was 51,1%. Patients with frailty and HF were characterized by worse exercise tolerance (NYHA class III-IV, 90,6% vs. 65,6%, pConclusion. The relevance of a comprehensive geriatric assessment in an elderly patient with HF is due to the high prevalence of frailty in this cohort of patients and its significant impact on the prognosis. Identification of frailty can help in making important clinical decisions, identifying a high-risk group for complications, and possibly optimizing treatment. Given that frailty can be potentially reversible, this particularly emphasizes the importance of optimizing HF therapy, on the one hand, and conducting a comprehensive frailty assessment in elderly patients with HF, on the other, to improve the prognosis of both diseases.


  • Open Access

    Molecular Biological Methods in The Etiological Diagnostics of Infective Endocarditis

    by E. O. Kotova, Zh. D. Kobalava, A. S. Pisaryuk, A. Yu. Moiseeva, E. A. Domonova

    Aim To study the role of early blood tests using the polymerase chain reaction (PCR) (before or at initial stages of antibacterial therapy, within the first 24-48 hours after diagnosis) for the diagnosis of infective endocarditis (IE) and improvement of the etiological algorithm. Material and methods The study included 154 patients with confirmed IE (DUKE, 2015) who underwent standard microbiological (culture) blood tests with a simultaneous molecular biological test (PCR study/sequencing) on the same type of biological material at the stage of primary diagnosis. Results In 117 (76.0%) examined patients, the etiologic agent was determined in blood samples by any of the methods used. Concordant results were obtained in 43 (36.8%) patients and discordant in 4 (3.4%) patients. In 29 (24.8%) patients, the causative agent of IE was determined only by the microbiological (cultural) examination of blood samples, and in 25 (21.4%) patients, only by the PCR study, including 3 cases of Bartonella spр. 23 patients had results of the microbiological (culture) blood tests that required clarification (70% CoNS, 26% gram-negative bacteria, one case of Enterococcus faecalis); 16 (69.6%) of 23 were not confirmed by the molecular biological method and were interpreted as contamination. In 1/3 of patients, the PCR blood study allowed increasing the accuracy of determining the causative agent of IE. Based on the integrated approach to the etiological diagnosis of IE, criteria for determining the causative pathogen were developed. This allowed reclassifying 9 (5.9%) diagnoses into the category of confirmed IE and to de-escalate the antibacterial therapy in every third examined patient. The microbiological and PCR studies of blood demonstrated comparable indexes of sensitivity, specificity and diagnostic accuracy [79.0, 86.0, 81.0% and 67.0, 93.0, 74.0%, respectively]. The PCR study of blood at the early stages of IE diagnosis (before or during the initial antibacterial therapy, within the first 24-48 hours after the IE diagnosis) is proposed as a control for Streptococcus spp., Staphylococcus aureus, CoNS, Enterococcus spр., and at the later stages of laboratory examination, especially in IE with an unspecified pathogen, as a priority method. Conclusion The PCR study of blood samples is a highly informative method for the etiological diagnosis of IE that allows increasing the accuracy of the pathogen identification in every third patient and, thus, prescribing an effective antibacterial therapy.


  • Open Access

    Cytokine profile of surgical patients with infective endocarditis

    by E. O. Kotova, A. S. Pisaryuk, A. V. Lokhonina, A. Y. Moiseeva, E. A. Domonova, T. A. Gusarova, J. I. Babukhina, P. V. Kakhktsyan, T. K. Fatkhudinov, Z. D. Kobalava

       Aim. To study the cytokine profile of macrophages in valve tissues in operated patients with infective endocarditis (IE), its correlation with inflammatory markers for optimization of the assessment of IE activity.  Material and methods. There were prospectively included 25 adult patients with active IE (2015Duke criteria) and 24 patients with non-IE valvular heart disease admitted for cardiac surgery (2021-2022). Laboratory and instrumental examination was conducted, including pathogen verification, as well by means of Real-Time PCR in blood/tissues of resected valves, echocardiography, and neutrophil-to-lymphocyte ratio evaluation. Valvular tissues were analyzed for macrophage phenotypic characteristics using immunohistochemistry (IHC) and for pro- and anti-inflammatory cytokine gene expression via real-time PCR.   Results. IE patients had a high proportion of secondary IE due to degenerative heart defects (n = 10, 40.0 %) and left-sided localization of IE (n = 16, 64.0 %). IHC revealed a predominance of intact pro-inflammatory CD 86+ macrophages phenotype in patients without IE compared with patients with IE [0.054 (0.029-0.073) vs. 0.008 (0.0071-0.0096), p < 0.05]. There was no significant difference in the anti-inflammatory CD 206+ macrophages phenotype. In the group of operated patients with IE, Real-Time PCR revealed significant expression of IL-1β genes (Ме [IQR] 0.0037 [0.0005-0.0155] vs. 0.0002 [0.0001-0.0026], p < 0.05) and IL-6 (Ме [IQR] 0.0034 [0.0007-0.0167] vs. 0.0005 [0.0004-0.0038], p < 0.05) compared with patients without IE. There were no significant differences in anti-inflammatory cytokines. The level of cytokine gene expression by tissue macrophages, depending on the presence of embolic events, etiological affiliation to S. aureus, as well as hospital mortality and the combined endpoint (death from all causes or recurrence of IE in 6 months after surgery) did not differ between IE patients with or without events. IL-1β had the most favorable characteristics for assessing the activity of IE (IL-1β AUC 0.816 (p = 0.02)).   Conclusion. Increased macrophages destruction with excessive release of pro-inflammatory cytokines in the valve tissue determines the uncontrolled course of IE and the need for cardiac surgery. IL-1β has a high diagnostic value for determining the inflammation activity in operated patients with IE.


  • Open Access

    Clinical Case of a Patient with Acute Tricuspid Valve Infective Endocarditis and A Multiplex Approach to Evaluation of The Complication Risk

    by E. O. Kotova, Zh. D. Kobalava, A. S. Pisaryuk, A. V. Lokhonina, A. Y. Moiseeva, E. A. Domonova, J. I. Babukhina, P. V. Kakhktsyan, Т. Kh. Fatkhudinov

    Infective endocarditis (IE) is characterized by the difficulty of diagnosis, treatment and risk assessment of an unfavorable prognosis. Currently there are no approved scales and calculators for the risk of complications and death that help the practitioner make decisions, especially in patients with isolated right-sided IE. For right-sided IE, the timing of successful surgical treatment remains uncertain. Previously developed risk calculators (Italian Rizzi calculator and French Hubert) are poorly validated in a wide population of patients with IE, especially for right-sided IE. One of the required parameters of calculators is the determination of etiological affiliation. However, with negative results of microbiological studies reaching 56-83 %, this parameter becomes uninformative. Moreover, existing risk assessment tools do not take into account the activity of the disease (including laboratory activity), which intuitively is an important guideline for every doctor in decision-making. At the moment, there is a great need for the introduction of molecular biological methods to improve the quality of etiological diagnosis and in-depth study of possible biomarkers from simple (neutrophil/lymphocytic, platelet/lymphocytic and systemic immuno-inflammatory index) to more complex (neutrophil extracellular traps, cytokine profile). We present a clinical case of a young patient with acute tricuspid valve IE with giant vegetation (28 mm), complicated by severe valvular insufficiency without signs of heart failure, recurrent embolic syndrome in the pulmonary artery system with the formation of pulmonary hypertension, determining indications for cardiac surgical treatment. The etiological affiliation of IE to Staphylococcus aureus was established only by PCR. The urgent timing of intervention was determined based on an increase in new markers — neutrophil/lymphocytic index ≥20.0, systemic immuno-inflammatory index ≥2314.0 and neutrophil extracellular traps ≥14.2, indicating an extremely high risk of death. A fundamental pathohistological study of the tissue material revealed a low content of intact CD86+ proinflammatory macrophages, probably associated with their excessive destruction and uncontrolled release of copious amounts of proinflammatory cytokines, which led to rapid and severe damage to the tricuspid valve. Thus, modern management of patients with IE should be multiplex using current methods of etiological and imaging diagnostics, and aimed at early detection of patients at adverse risk for a timely differentiated approach to conservative or cardiac surgical treatment tactics.


  • Open Access

    Proinflammatory cytokines IL-6, IL-1β, TNF-α in infective endocarditis

    by Elizaveta Kotova, Alexandra Moiseeva, Zhanna Kobalava, Anastasiya Lokhonina, Alexandra Pisaryuk, Tatyana Gusarova, Timur Fatkhudinov, Elvira Domonova

    Aim. To study the features of macrophages in the tissues of resected valves in operated patients with infective endocarditis (IE), their significance and interaction with inflammatory markers to improve the effectiveness of IE diagnosis. Materials and methods. Prospectively the research included 25 adult patients with active IE (Duke criteria 2015) and 24 patients with heart defects without IE, hospitalized in a cardiosurgical hospital in Moscow (2021–2022). A standard laboratory and instrumental examination was carried out for the diagnosis of IE, including etiological diagnosis with microbiological and molecular biological methods, and echocardiographic examination of heart. Additionally, the neutrophil-to-lymphocyte ratio (NLR) was calculated. The study of macrophages was carried out in the tissues of resected valves with the determination of the expression of pro- and anti-inflammatory cytokine genes, macrophage markers (CD 68+) using real-time PCR. Results. Increased expression of proinflammatory cytokines IL-1β, TNF-α and IL-6 was revealed in the group of operated patients with IE with significant differences in IL-1β (CI [IQR] 0.00367 [0.00047–0.01553] vs 0.00018 [0.00012–0.00262]; p0.05) and IL-6 (CI [IQR] 0.00367 [0.00047–0.01553] vs 0.00018 [0.00012–0.00262]; p0.05) and IL-6 (CI [IQR] 0.00338 [0.00066–0.01674] vs 0.00054 [0.00044–0.00378]; p0.05). The expression of anti-inflammatory cytokines in valve tissues prevailed in the control group without significant differences from patients with IE. The macrophage marker CD 68+ was revealed in all examined patients with a significant quantitative predominance in the group of patients with IE. There were no differences in the expression of pro- and anti-inflammatory cytokines depending on the presence of embolic events, intracardiac complications, etiological affiliation to S. aureus, as well as hospital mortality and combined endpoint (death from all causes or recurrence of IE 6 months after surgery) in patients with IE with or without events. Cytokines IL-1β and IL-6 positively correlated with each other, with leukocytes and NLR. ROC analysis determined that IL-1β and NLR had the most favorable features for the diagnosis of IE [IL-1β AUC 0.816 (p=0.02), NLR AUC 0.807 (p=0.03)]. IL-6 did not show a diagnostic value in IE. The threshold value for IL-1β was 0.00029 (sensitivity 86.4%, specificity 60.0%, prognostic value of negative result 75.0% and positive 76.0%, AUC 0.761; p=0.008). Conclusion. The valve macrophages of patients with IE express elevated levels of proinflammatory cytokines IL-1β and IL-6, regardless of etiological affiliation or complicated course of IE. IL-1β has a high diagnostic value for determining the inflammatory activity in IE.


  • Open Access

    Practical approaches to antimicrobial therapy for infective endocarditis in the context of national and European clinical guidelines

    by E. O. Kotova, Zh. D. Kobalava

    Infective endocarditis (IE) is a rare disease with a potentially high mortality rate. The patient "portrait" is changing, there is an increase in the proportion of elderly people with concomitant diseases and degenerative defects, prosthetic valves and minimally invasive cardiac operations, implanted intracardiac devices, and hemodialysis. An additional significant negative contribution is made by the transformation of the etiological picture — an increase in the species diversity of pathogens, a decrease in the proportion of streptococci, a steady increase in the staphylococcal and enterococcal etiology of IE. The IE treatment success depends on the competent administration of antibacterial therapy. Clinicians are guided by two main documents: the national clinical guidelines "Infective endocarditis and infection of intracardiac devices" of 2021 and the European clinical guidelines "ESC Guidelines for the management of endocarditis" of 2023. The article summarizes updated data on the optimal prescription of antibacterial therapy, presented in a convenient and understandable format for the practicing physicians. Schemes for prescribing intravenous antibiotic therapy in a hospital are presented not only for traditional pathogens (Staphylococcus sp., Streptococcus sp. and Enterococcus sp.), but also for rare pathogens that cause significant difficulties (pathogens of the HACEK and non-HACEK group, Coxiella burnetii, Bartonella sp., Brucella sp., Tropheryma whipplei, Mycobacterium sp., fungi). Separately, the principles of empirical antibacterial therapy with the most effective treatment regimens not only for left-sided IE, but also for different variants of right-sided IE are presented in detail. New modern possibilities of outpatient oral antibiotic therapy for IE are presented. In conclusion, prospects for the development of conservative IE treatment are proposed.


  • Open Access

    History of the study of infective endocarditis in Russia

    by Julia Karaulova, Elizaveta Kotova, Alexandra Pisaryuk, Nikita Povalyaev, Zhanna Kobalava

    The history of the study of infective endocarditis in Russia is described in the article.


  • Open Access

    Neutrophil extracellular traps as a promising marker of poor prognosis in operated patients with infective endocarditisarditis.

    by E. O. Kotova, A. Yu. Moiseeva, Zh. D. Kobalava, A. S. Pisyaryuk, D. V. Kassina, A. S. Gur’eV, T. A. Gusarova

    Aim. To assess the prognostic value of the formation of neutrophil extracellular traps (NETs) in blood smears of operated patients with infective endocarditis (IE).Material and methods. We prospectively included 46 patients with verified IE and 50 patients with valvular heart disease without IE, hospitalized in a cardiac surgery hospital in 2021-2022 (Moscow), comparable by sex and age. In all patients, NETs were determined upon admission and 7 days after surgery using the MECOS-Ts2 automated microscope (Russia). Patients included in the study were prospectively followed during the in-hospital period (ME [IQR] 30,0 [21,0-41,0] days) for the primary composite endpoint (in-hospital all-cause mortality, embolic, intracardiac, infectious complications) and its individual components.Results. Patients with IE were predominantly male (n=37, 80,4%) with a median age of 55,5 [44,0-70,0] years. The primary combined endpoint was recorded in 76,1% (n=35) of those examined with IE. The NET level after 7 days was significantly higher in patients with IE who had primary combined endpoint events than in the group of operated patients with heart defects without IE (Me [IQR] 4,4 [0,6-26,6] vs 2,9 [1,1-4,3], respectively, pConclusion. The NET level in blood smears of operated patients with IE is a new promising marker for predicting the disease complicated course. NETs ≥11,2% in operated patients with IE increase the probability of hospital mortality by 24 times and postoperative sepsis by 22 times.